Group 1 - The core viewpoint of the news is that Baiao Chemical's stock price increased by 5.14% to 29.85 CNY per share, with a trading volume of 307 million CNY and a turnover rate of 1.49%, resulting in a total market capitalization of 21.081 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone-based industrial biocides [1] - The company's main business revenue composition includes industrial biocides at 54.95%, semiconductors at 44.36%, key components and consumables at 0.23%, by-products at 0.23%, and others at 0.22% [1] Group 2 - Southern Fund's Southern CSI 1000 ETF (512100) is among the top ten circulating shareholders of Baiao Chemical, having reduced its holdings by 45,500 shares to 3.2256 million shares, representing 0.46% of the circulating shares [2] - The Southern CSI 1000 ETF has achieved a year-to-date return of 8.02% and a one-year return of 33.83%, ranking 1604 out of 5580 and 1868 out of 4297 in its category, respectively [2] - The fund manager, Cui Lei, has been in position for 7 years and 111 days, with the fund's total asset size at 137.02 billion CNY and a best return of 250.66% during the tenure [3]

Group 1 - Baiao Chemical's stock price dropped by 5.09% to 28.91 CNY per share, with a trading volume of 358 million CNY and a turnover rate of 1.72%, resulting in a total market capitalization of 20.417 billion CNY [1] - The company, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone-based industrial biocides [1] - The revenue composition of Baiao Chemical includes 54.95% from industrial biocides, 44.36% from semiconductors, 0.23% from key components and consumables, and 0.22% from other sales [1] Group 2 - Southern Fund's Southern CSI 1000 ETF (512100) is among the top ten circulating shareholders of Baiao Chemical, having reduced its holdings by 45,500 shares to 3.2256 million shares, representing 0.46% of circulating shares [2] - The estimated floating loss for the Southern CSI 1000 ETF today is approximately 4.9996 million CNY [2] - The fund has a total asset size of 78.996 billion CNY and has achieved a year-to-date return of 6%, ranking 1533 out of 5579 in its category [2]

Core Viewpoint - Baiao Chemical's stock has experienced fluctuations, with a recent decline of 2.01% and a total market capitalization of 22.394 billion yuan. The company is involved in the research, production, and sales of industrial biocides, primarily isothiazolinones, and has seen mixed financial performance in recent periods [1][2]. Group 1: Stock Performance - As of January 6, Baiao Chemical's stock price was 31.71 yuan per share, with a trading volume of 255 million yuan and a turnover rate of 1.13% [1]. - Year-to-date, the stock has decreased by 1.58%, with a slight increase of 1.47% over the last five trading days and a notable increase of 15.27% over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Baiao Chemical reported a revenue of 1.056 billion yuan, reflecting a year-on-year growth of 17.88%. However, the net profit attributable to shareholders decreased by 50.83% to 125 million yuan [2]. - Cumulatively, since its A-share listing, Baiao Chemical has distributed a total of 1.224 billion yuan in dividends, with 722 million yuan distributed over the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of Baiao Chemical's shareholders increased by 12.51% to 24,000, while the average number of circulating shares per person decreased by 11.12% to 29,483 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 4.0587 million shares, an increase of 1.6304 million shares from the previous period, while the Southern CSI 1000 ETF reduced its holdings by 45,500 shares [3].

Core Viewpoint - Baiao Chemical's stock has shown significant growth this year, with a year-to-date increase of 106.16%, indicating strong market performance and investor interest [1][2]. Group 1: Stock Performance - As of December 29, Baiao Chemical's stock price reached 31.88 yuan per share, with a trading volume of 1.38 billion yuan and a turnover rate of 0.62%, resulting in a total market capitalization of 22.514 billion yuan [1]. - The stock has experienced a net inflow of 12.37 million yuan from major funds, with large orders accounting for 24.28% of total purchases [1]. - The stock has appeared on the "Dragon and Tiger List" four times this year, with the most recent appearance on December 15, where it recorded a net buy of -13.51 million yuan [1]. Group 2: Company Overview - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, is located in Dalian, Liaoning Province, and specializes in the research, production, and sales of isothiazolinone industrial biocides [2]. - The company's revenue composition includes 54.95% from industrial biocides, 44.36% from semiconductors, and minor contributions from other segments [2]. - As of September 30, the number of shareholders increased by 12.51% to 24,000, while the average circulating shares per person decreased by 11.12% [2]. Group 3: Financial Performance - For the period from January to September 2025, Baiao Chemical reported a revenue of 1.056 billion yuan, reflecting a year-on-year growth of 17.88%, while the net profit attributable to shareholders decreased by 50.83% to 125 million yuan [2]. - The company has distributed a total of 1.224 billion yuan in dividends since its A-share listing, with 722 million yuan distributed over the past three years [3]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited increased its holdings by 1.6304 million shares, while the Southern CSI 1000 ETF reduced its holdings by 45,500 shares [3].

Core Viewpoint - Baiao Chemical's stock has shown significant volatility, with a year-to-date increase of 98.27%, but recent trends indicate a slight decline in the short term [1][2]. Group 1: Stock Performance - On December 26, Baiao Chemical's stock rose by 2.03%, reaching 30.66 CNY per share, with a trading volume of 1.04 billion CNY and a turnover rate of 0.48%, resulting in a total market capitalization of 21.653 billion CNY [1]. - The stock has experienced a 0.10% decline over the last five trading days and a 9.16% decline over the last 20 days, while it has increased by 20.05% over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" four times this year, with the most recent appearance on December 15, where it recorded a net buy of -13.5148 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Baiao Chemical reported a revenue of 1.056 billion CNY, reflecting a year-on-year growth of 17.88%, while the net profit attributable to shareholders decreased by 50.83% to 125 million CNY [2]. - The company has distributed a total of 1.224 billion CNY in dividends since its A-share listing, with 722 million CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of September 30, 2025, Baiao Chemical had 24,000 shareholders, an increase of 12.51% from the previous period, with an average of 29,483 circulating shares per shareholder, a decrease of 11.12% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 4.0587 million shares, an increase of 1.6304 million shares from the previous period, while Southern CSI 1000 ETF reduced its holdings by 45,500 shares [3].

Group 1 - The core point of the news is that Baiao Chemical's stock price has dropped by 5%, currently trading at 32.28 CNY per share, with a total market capitalization of 22.797 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone industrial biocides [1] - The company's main business revenue composition includes industrial biocides (54.95%), semiconductors (44.36%), key components and consumables (0.23%), by-products (0.23%), and others (0.22%) [1] Group 2 - Huatai Baoxing Fund holds a significant position in Baiao Chemical, with its fund "Huatai Baoxing Industrial Upgrade Mixed Initiation A" (021792) owning 70,000 shares, accounting for 5.03% of the fund's net value [2] - The fund has experienced a floating loss of approximately 119,000 CNY today [2] - The fund was established on September 24, 2024, with a current scale of 19.6441 million CNY and has achieved a year-to-date return of 47.73% [2]

Group 1 - The stock price of Baiao Chemical dropped by 5% to 32.28 CNY per share, with a trading volume of 441 million CNY and a turnover rate of 1.89%, resulting in a total market capitalization of 22.797 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone-based industrial biocides, with its main business revenue composition being 54.95% from industrial biocides, 44.36% from semiconductors, and 0.46% from other products [1] Group 2 - Zhongyin Securities holds a significant position in Baiao Chemical through its fund, Zhongyin Securities Preferred Industry Leaders Mixed A (009640), which increased its holdings by 106,700 shares in the third quarter, totaling 355,000 shares, accounting for 9.58% of the fund's net value [2] - The fund has a current scale of 62.0185 million CNY and has achieved a year-to-date return of 56.34%, ranking 499 out of 8,138 in its category, with a one-year return of 53.56%, ranking 674 out of 8,055 [2]

Core Viewpoint - Baiao Chemical's stock has shown significant growth this year, with a year-to-date increase of 119.15%, indicating strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Baiao Chemical achieved a revenue of 1.056 billion yuan, representing a year-on-year growth of 17.88% [2]. - The net profit attributable to shareholders for the same period was 125 million yuan, which reflects a substantial decrease of 50.83% compared to the previous year [2]. Stock Market Activity - As of November 12, Baiao Chemical's stock price was 33.89 yuan per share, with a trading volume of 327 million yuan and a turnover rate of 1.40% [1]. - The company has appeared on the stock market's "Dragon and Tiger List" three times this year, with the most recent occurrence on August 28 [1]. Shareholder Information - As of September 30, the number of shareholders for Baiao Chemical increased by 12.51% to 24,000, while the average number of circulating shares per person decreased by 11.12% to 29,483 shares [2]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 4.0587 million shares, an increase of 1.6304 million shares from the previous period [3]. Business Overview - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone-based industrial biocides [1]. - The company's revenue composition includes 54.95% from industrial biocides and 44.36% from semiconductors, with minor contributions from other segments [1].

Core Viewpoint - Baiao Chemical's stock has shown significant growth this year, with a year-to-date increase of 108.74%, indicating strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Baiao Chemical achieved a revenue of 1.056 billion yuan, representing a year-on-year growth of 17.88% [2]. - The net profit attributable to shareholders for the same period was 125 million yuan, which reflects a substantial decrease of 50.83% compared to the previous year [2]. Stock Market Activity - As of November 11, Baiao Chemical's stock price was 32.28 yuan per share, with a market capitalization of 22.797 billion yuan [1]. - The stock has seen a trading volume of 1.16 billion yuan and a turnover rate of 0.51% on the same day [1]. - The stock has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on August 28 [1]. Shareholder Information - As of September 30, 2025, the number of shareholders increased by 12.51% to 24,000, while the average circulating shares per person decreased by 11.12% to 29,483 shares [2][3]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 4.0587 million shares, an increase of 1.6304 million shares from the previous period [3]. Dividend Distribution - Since its A-share listing, Baiao Chemical has distributed a total of 1.224 billion yuan in dividends, with 722 million yuan distributed over the past three years [3].

Group 1 - The core point of the news is that Baiao Chemical's stock price has dropped by 5.19%, currently trading at 31.26 CNY per share, with a total market capitalization of 22.077 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone industrial biocides [1] - The company's main business revenue composition includes industrial biocides at 54.95%, semiconductors at 44.36%, and other minor segments [1] Group 2 - According to data, a fund under Bank of China Securities has heavily invested in Baiao Chemical, with the fund increasing its holdings by 106,700 shares in the third quarter, bringing the total to 355,000 shares, which constitutes 9.58% of the fund's net value [2] - The fund, named Bank of China Securities Preferred Industry Leaders Mixed A (009640), has a total scale of 62.0185 million CNY and has achieved a year-to-date return of 60.17% [2] - The fund manager, Song Fangyun, has been in position for 2 years and 317 days, with the best fund return during this period being 22.23% and the worst being -39.29% [3]